Lv11
40 积分 2022-05-31 加入
Standardized Definitions for Efficacy End Points in Neoadjuvant Breast Cancer Clinical Trials: NeoSTEEP
2小时前
已完结
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
4天前
已完结
Perioperative camrelizumab plus rivoceranib versus surgery alone in patients with resectable hepatocellular carcinoma at intermediate or high risk of recurrence (CARES-009): a randomised phase 2/3 trial
5天前
已完结
[Recommendations for the diagnosis and treatment of gout in China]
1个月前
已完结
Pien Tze Huang Protects Against Non-Alcoholic Steatohepatitis by Modulating the Gut Microbiota and Metabolites in Mice
1个月前
已完结
Changing cancer survival in China during 2003–15: a pooled analysis of 17 population-based cancer registries
1个月前
已完结
Predictors and patterns of recurrence after radiofrequency ablation for hepatocellular carcinoma within up-to-seven criteria: A multicenter retrospective study
1个月前
已完结
Fibrosis score impacts survival following resection for hepatocellular carcinoma (HCC): A Surveillance, End Results and Epidemiology (SEER) database analysis
1个月前
已完结
[Assessment of healthy related quality of life in patients with HBV induced liver cirrhosis]
1个月前
已关闭
Prognostic value of cirrhosis in intermediate and advanced hepatocellular carcinoma: a multicenter cohort study
1个月前
已关闭
皖公网安备34019202002308
